Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|10|1191-1197

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.10, 2016-04, pp. : 1191-1197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD8+ T-cells: Are They Sufficient to Prevent, Contain or Eradicate HIV-1 Infection?

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 113-119

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-01 ,pp. : 348-356

Bentham Science Publishers

Access to resources Recommend Favorite

CD4+CD25+ regulatory T cells: a therapeutic target for liver diseases

By Zheng Ming-Hua   Gu Dian-Na   Braddock Martin   Leishman Andrew J   Jin Chang   Wen Jin-Sheng   Gong Yue-Wen   Chen Yong-Ping  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 313-326

Informa Healthcare

Access to resources Recommend Favorite

The Generation and Antigen-Specificity of CD4+CD25+ Regulatory T Cells

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle

By  

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 16-28

Bentham Science Publishers

Access to resources Recommend Favorite